Imperial College London

Professor Francis Drobniewski

Faculty of MedicineDepartment of Infectious Disease

Chair in Global Health and Tuberculosis







Commonwealth BuildingHammersmith Campus




Guest Lectures

How do clinicians help people to do the right thing?, University of Malta, 2024

Management and Leadership in Healthcare:The realities of quality compassionate leadership rather than poor management, MSc in Health Management, City University of London, 2022

TB Diagnosis-Global Progress, Problem Solved?, Federation Infection Societies International Conference, Newcastle, 2018

Current and future technical options for thediagnosis of drug resistant tuberculosis, Institut Pasteur and Shenzhen CDC, Shenzhen, China, 2018

: Management of mycobacterial infections and associated comorbidities., ESCMID and ESCMID Study Group for Mycobacterial Infections, Rome, 2018

Tuberculosis:from molecular diagnosis, drug susceptibilitytesting and genome sequencing to treatment of MDR and XDR-TB., Institut Pasteur, Paris, Francis, 2017

Investing in prevention or in treatment of MDR-TB?, European Society Clinical Microbiology and Infectious Diseases--Study Group for Mycobacterial Diseases Course -Difficult to treat Mycobacterial infections, Brac , Coratia, 2016

Clinical implications of molecular drug resistance testing in tuberculosis-focus on the value of NGS, School of Public Health, Fudan University, Shanghai, CHina, 2016

Tuberculous resistance: value of rapid testing in various infrastructure settings, Chinese Academy of Medical Sciences and Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China, 2016

Opportunities and challenges in whole genome sequencing for TB prevention and control, European Respiratory Society International Conference, London, 2016

TB genomics and diagnosis--the future or hype?, British Thoracic Society-Symposium New Directions in TB diagnostics and therapy, Queen Elizabeth Center, london, 2015

Tuberculosis Genomics: Improving Diagnostics, American Thoracic Society International Conference, Denver, 2015

MDRTB-an update on diagnosis and management, Croatia Pulmonology Congress, Dubrovnik, Croatia, 2014

Conundrums in Tuberculosis: Update on X/MDRTB, American Society for Microbiology Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, 2014

Development and use of Novel TB Therapies Including Trials, Congress of European Society for Mycobacteriology, Vienna, Austria, 2014

Genotypic Methods for Susceptibility Determination of Mycobacterium tuberculosis, American Society for Microbiology ICAAC, Denver, Colorado, USA, 2013

TB-White Plague -Current challenges of drug resistance, European Society Clinical Microbiology and Infectious Diseases -St George's Conference on Drug Resistance, Verona, 2013

Research Student Supervision

Braganza,L, Overcoming COVID-19 vaccination hesitancy amongst medical student populations in England using a self-report survey and a literature review to develop communication strategies and implementation

Chan,HTM, A systematic review of the safety and otoprotective efficacy of sodium thiosulphate on aminoglycoside-/cisplatin-induced ototoxicity

Cheong,J, Health-economic implications of aminoglycoside-induced ototoxicity

Gurpreet,B, Diagnosing Active Pulmonary Tuberculosis using Non-Invasive Samples

He,T, The value of biomarkers in understanding mycobacterial diseases such as tuberculosis

He,T, Value of novel host and pathogen biomarkers in the diagnosis and prognosis of mycobacterial infections

Rui,YS, Analysis of mycobacteria using lipid fingerprints in MALDI-ToF MS on intact bacteria

gonzalo,X, Improving diagnostic approaches in extensive and multidrug resistant tuberculosis: new diagnostic tools and repurposing drugs against X/MDRTB

hamilton,C, The role of NOD-like receptors in innate immune responses